Latest News
Featured News
Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Block Listing Return and Total Voting Rights
Change of Nominated Advisor
It is with great sadness that Scancell announces the death of former Chairman John Chiplin
Scancell founder says the company is ready to commercialise novel medicines to counteract cancer
Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab® Portfolio
Scancell receives MHRA approval to expand ModiFY trial
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.